191 related articles for article (PubMed ID: 12760267)
1. Primary non-Hodgkin's lymphoma of the bladder with bone marrow involvement.
Oh KC; Zang DY
Korean J Intern Med; 2003 Mar; 18(1):40-4. PubMed ID: 12760267
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Conlan MG; Bast M; Armitage JO; Weisenburger DD
J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
[TBL] [Abstract][Full Text] [Related]
3. [A bulky mass non-Hodgkin's lymphoma with dysuria in the rectovesical space].
Tosaka A; Yamazaki A; Hirokawa M; Matsushita K; Asakura S
Hinyokika Kiyo; 1990 Jun; 36(6):701-5. PubMed ID: 2239564
[TBL] [Abstract][Full Text] [Related]
4. [Primary malignant lymphoma of the urinary bladder: report of a case].
Murayama K; Katsumi T; Watanabe K; Konishi K
Hinyokika Kiyo; 1990 Jun; 36(6):697-700. PubMed ID: 2239563
[TBL] [Abstract][Full Text] [Related]
5. [Primary malignant lymphoma of the urinary bladder: a case report].
Koike H; Morita T; Tamura Y
Nihon Hinyokika Gakkai Zasshi; 2004 May; 95(4):675-8. PubMed ID: 15198002
[TBL] [Abstract][Full Text] [Related]
6. [Primary malignant lymphoma of the urinary bladder achieving complete response by COMPA intraarterial chemotherapy: a case report].
Ueda T; Yamauchi T; Kageyama S; Tsuzuki M; Kawakami S; Yonese J; Kawai T
Nihon Hinyokika Gakkai Zasshi; 1994 Jun; 85(6):1006-9. PubMed ID: 8065071
[TBL] [Abstract][Full Text] [Related]
7. Primary non-Hodgkin's lymphoma of the bladder: case report and literature review.
Mahfoud T; Tanz R; Mesmoudi M; Khmamouche MR; El Khannoussi B; Ichou M; Errihani H
Pan Afr Med J; 2013; 15():136. PubMed ID: 24319526
[TBL] [Abstract][Full Text] [Related]
8. [A case of primary malignant lymphoma of the bladder].
Nishida S; Kuroko K; Hoshino T; Iwamoto T; Shirai C
Hinyokika Kiyo; 1998 Aug; 44(8):599-601. PubMed ID: 9783199
[TBL] [Abstract][Full Text] [Related]
9. Primary non-Hodgkin's lymphoma of the urinary bladder.
Melekos MD; Matsouka P; Fokaefs E; Pantazakos A; Repanti M
Eur Urol; 1992; 21(1):85-8. PubMed ID: 1606990
[TBL] [Abstract][Full Text] [Related]
10. [A case of secondary malignant lymphoma of the urinary bladder].
Yokoyama M; Kobayashi T; Kubo Y; Kageyama Y; Kihara K
Hinyokika Kiyo; 2006 Apr; 52(4):285-7. PubMed ID: 16686357
[TBL] [Abstract][Full Text] [Related]
11. [Non-Hodgkin's lymphoma with primary localization in the bladder and prostate region. Description of a case].
Mahlknecht A; Gallmetzer J
Minerva Urol Nefrol; 1995 Mar; 47(1):39-41. PubMed ID: 7570259
[TBL] [Abstract][Full Text] [Related]
12. False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
Inoue Y; Tamaki H; Yamagami T; Iwasaki H; Nakatsuka S; Soma T
Eur J Haematol; 2007 Jul; 79(1):88-90. PubMed ID: 17532762
[No Abstract] [Full Text] [Related]
13. Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report.
Pirozzi A; Cartenì G; Scagliarini S; Fusco M; Riccardi F
Medicine (Baltimore); 2019 Mar; 98(11):e14805. PubMed ID: 30882658
[TBL] [Abstract][Full Text] [Related]
14. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM
Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771
[TBL] [Abstract][Full Text] [Related]
15. Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.
Janicek M; Kaplan W; Neuberg D; Canellos GP; Shulman LN; Shipp MA
J Clin Oncol; 1997 Apr; 15(4):1631-7. PubMed ID: 9193363
[TBL] [Abstract][Full Text] [Related]
16. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
[TBL] [Abstract][Full Text] [Related]
17. [Lactic acidosis in non-Hodgkin's lymphoma].
Navigante AH; Chacón RD
Medicina (B Aires); 1985; 45(6):667-9. PubMed ID: 2431249
[No Abstract] [Full Text] [Related]
18. Treatment of prognosis of primary breast lymphoma: a review of 13 cases.
Lyons JA; Myles J; Pohlman B; Macklis RM; Crowe J; Crownover RL
Am J Clin Oncol; 2000 Aug; 23(4):334-6. PubMed ID: 10955857
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphomas in Turkey: eighteen years' experience at the Hacettepe University.
Barista I; Tekuzman G; Firat D; Baltali E; Kansu E; Kars A; Ozisik Y; Ruacan S; Uzunalimoğlu B; Karaağaoğlu E
Jpn J Cancer Res; 1994 Dec; 85(12):1200-7. PubMed ID: 7531679
[TBL] [Abstract][Full Text] [Related]
20. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
